Mark Barnett has cut some of former manager Neil Woodford's favourite holdings in the £1.4bn Edinburgh investment trust, adding 14 new stocks since the beginning of the year.
The manager has cut positions in AstraZeneca, BT Group, Capita, GlaxoSmithKline and ReckittBenckiser, and has made new investments in Babcock International, Beazley, BP, Brown (N), CLS, Compass, Derwent London, KCOM, London Stock Exchange, NewRiver Retail, Reed Elsevier, Shaftesbury, Thomas Cook and Vectura. The trust returned 12.5% at NAV for the year to 31 March, beating the benchmark FTSE All Share return of 8.8% over the period. However, the departure of Neil Woodford left a dent in the company’s share price, with the discount moving from 1.7% to 5.4%. On a share price basis, t...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes